NIAID supports the maintenance and distribution of materials for biomedical research. Items such as pathogen, host, and vector specimens; molecular reagents; and disease models belong in the public domain, to be used to pursue science that can improve the health of people worldwide. This technology is generally not meant for broad commercialization or sale to the public and so is not patented.
Content last reviewed on December 8, 2015